Revlon, Inc. (REV) Announces Plans to Reduce Corporate Debt by $170 Million
Source: http://Blog.QualityStocks.net/?p=12160Posted on Friday, September 5th, 2008 | In Small & Micro Cap
Revlon, Inc. (NYSE: REV), a worldwide cosmetics, skin care, fragrance, and personal care products company that delivers the promise of beauty through creation and development, recently announced that the company plans to reduce its debt by $170 million by repaying the $170 million MacAndrews & Forbes Senior Subordinated Term Loan (the “M&F Term Loan”) that matures on August 1, 2009.
Management will achieve this debt reduction in two steps. First, the company will use $63 million of the net proceeds from the sale of its Bozzano business in Brazil to repay a significant portion of the $170 million M&F Term Loan. Secondly, Revlon intends to launch, as early as in the fourth quarter of 2008, a $107 million equity rights offering that would allow stockholders to purchase additional shares of Revlon Class A common stock. Revlon intends to use the net proceeds of such equity issuance to fully repay the remaining balance of the M&F Term Loan.
Commenting on the company’s debt reduction strategy, Revlon president and chief executive officer, David Kennedy recently stated, “By repaying the M&F Term Loan, we will eliminate our highest cost, nearest maturity debt, which carries an annual cash interest cost of almost $19 million. Improving our capital structure with this important step is consistent with a key aspect of our strategy.”
Let us hear your thoughts below:
Last 5 posts by QualityStocks
- Omnicity Corp. (OMCY.OB) Announces Addition of New Board Member - November 20th, 2009
- Muscle Flex, Inc. (MFLI.PK) Announces Release Time for the BUDDY Tablet Caddy Two-Minute Commercial and Landing Page - November 20th, 2009
- Artfest International, Inc. (ARTS.OB) Announces Revenue Profit Jumps - November 20th, 2009
- Omnicity Corp.’s (OMCY.OB) Recently-Issued Corporate Update - November 20th, 2009
- Soligenix Inc. (SNGX.OB) Taking Steps to Meet Challenges of Vaccine Technology and Biological Warfare - November 20th, 2009
![]() About QualityStocks (http://QualityStocks.net)
Our name, QualityStocks, emphasizes our commitment to connect subscribers with companies that have huge potential to succeed in the short and long-term future. We believe strong management and vision for the future are crucial for any company to be successful. Timing is everything and we help investors succeed by providing an objective, broad-based view of the SmallCap markets on a daily basis. Please see disclaimer on QualityStocks website: http://disclaimer.qualitystocks.net |



